UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060951
Receipt number R000069573
Scientific Title Determination of the Clinical Equipotent Dose Ratio of Remimazolam to Propofol in Colonoscopy: The RECIPE-C Study (Remimazolam Equipotent Conversion Index to Propofol in Endoscopy-Colon)
Date of disclosure of the study information 2026/03/17
Last modified on 2026/03/16 18:38:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Determination of the Clinical Equipotent Dose Ratio of Remimazolam to Propofol in Colonoscopy: The RECIPE-C Study (Remimazolam Equipotent Conversion Index to Propofol in Endoscopy-Colon)

Acronym

RECIPE-C Study

Scientific Title

Determination of the Clinical Equipotent Dose Ratio of Remimazolam to Propofol in Colonoscopy: The RECIPE-C Study (Remimazolam Equipotent Conversion Index to Propofol in Endoscopy-Colon)

Scientific Title:Acronym

RECIPE-C Study

Region

Japan


Condition

Condition

Patients undergoing colonoscopy (for screening or diagnostic purposes)

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

1. To calculate the clinical equipotent dose ratio of RMZ to PRO in the same patients under opioid-free conditions.
2. To verify whether RMZ alone enables colonoscopy completion equivalent to PRO alone.
3. To evaluate differences in safety and quality of recovery.

Basic objectives2

PK,PD

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Dose weight ratio (weight-adjusted total dose)

For each patient, the ratio of weight-adjusted doses calculated using the following formula (median and correlation coefficient):
Dose Weight Ratio (mg/kg) = Total Dose (mg) / Weight (kg)

Comparison of RMZ and PRO to derive the RMZ-to-PRO conversion ratio.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Aged 20 years or older with opt-out consent obtained
Underwent colonoscopy for screening or diagnostic purposes with RMZ as the sedative
Had a colonoscopy under PRO monotherapy (opioid-free) at our institution within the past 2 years, completed by a single operator with a single scope to cecal intubation
Procedures performed by an expert endoscopist (board-certified gastroenterologist with >=2,000 colonoscopy experience) in both prior and current examinations

Key exclusion criteria

Change in ASA PS classification between prior and current examinations
History of colorectal surgery (except appendectomy)
Emergency endoscopy
Cases where procedural difficulty, invasiveness, or examination time was judged significantly different between prior and current examinations (e.g., therapeutic endoscopy such as ESD/EMR, severe adhesions, strictures)
Cold snare polypectomy for <=4 lesions is NOT excluded
Pregnant or possibly pregnant
Currently receiving opioids (including tramadol)
Judged inappropriate by the attending physician

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Shimizu

Organization

Sendai City Medical Center Sendai Open Hospital

Division name

Department of Gastroenterology

Zip code

983-0824

Address

5-22-1, Tsurugaya, Miyagino-ku, Sendai, Miyagi, Japan

TEL

022-252-1111

Email

takeshi.shimizu@openhp.or.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Shimizu

Organization

Sendai City Medical Center Sendai Open Hospital

Division name

Department of Gastroenterology

Zip code

983-0824

Address

Sendai City Medical Center Sendai Open Hospital

TEL

022-252-1111

Homepage URL


Email

takeshi.shimizu@openhp.or.jp


Sponsor or person

Institute

Sendai City Medical Center Sendai Open Hospital

Institute

Department

Personal name



Funding Source

Organization

self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sendai City Medical Center Sendai Open Hospital

Address

5-22-1, Tsurugaya, Miyagino-ku, Sendai, Miyagi, Japan

Tel

022-252-1111

Email

masayuki.mori@openhp.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 02 Month 19 Day

Date of IRB

2026 Year 02 Month 19 Day

Anticipated trial start date

2026 Year 03 Month 02 Day

Last follow-up date

2026 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

N/A


Management information

Registered date

2026 Year 03 Month 16 Day

Last modified on

2026 Year 03 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069573